ABIONYX Pharma SA (BST:609)
1.388
-0.148 (-9.64%)
At close: Nov 20, 2026
| Market Cap | 60.21M -58.9% |
| Revenue (ttm) | 4.06M -10.7% |
| Net Income | -5.55M |
| EPS | -0.16 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 37,293 |
| Open | 1.524 |
| Previous Close | 1.536 |
| Day's Range | 1.388 - 1.534 |
| 52-Week Range | 1.388 - 4.260 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Dec 24, 2026 |